Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Effect of Clinical Decision-Support Systems
2012818 citationsTiffani J Bright, Anthony Wong et al.Annals of Internal Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Michael Musty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Musty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Musty more than expected).
This network shows the impact of papers produced by Michael Musty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Musty. The network helps show where Michael Musty may publish in the future.
Co-authorship network of co-authors of Michael Musty
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Musty.
A scholar is included among the top collaborators of Michael Musty based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Michael Musty. Michael Musty is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sanders, Gillian D, Manesh R. Patel, Ranee Chatterjee, et al.. (2013). Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs.2 indexed citations
9.
Havrilesky, Laura J., Jennifer M. Gierisch, Patricia G. Moorman, et al.. (2013). Oral contraceptive use for the primary prevention of ovarian cancer.. PubMed. 1–514.35 indexed citations
10.
McCrory, Douglas C, Remy R Coeytaux, William S. Yancy, et al.. (2013). Assessment and Management of Chronic Cough.7 indexed citations
11.
McCrory, Douglas C, Remy R Coeytaux, William S. Yancy, et al.. (2013). DATA ABSTRACTION ELEMENTS.
Bright, Tiffani J, Anthony Wong, Dhurjati Ravi, et al.. (2012). Effect of Clinical Decision-Support Systems. Annals of Internal Medicine. 157(1). 29–43.818 indexed citations breakdown →
14.
Dolor, Rowena J, Chiara Melloni, Ranee Chatterjee, et al.. (2012). Treatment strategies for women with coronary artery disease.13 indexed citations
15.
Lobach, David F., Gillian D Sanders, Tiffani J Bright, et al.. (2012). Enabling health care decisionmaking through clinical decision support and knowledge management.. PubMed. 1–784.133 indexed citations
16.
Dolor, Rowena J, Chiara Melloni, Ranee Chatterjee, et al.. (2012). Treatment Strategies for Women With Coronary Artery Disease [Internet].2 indexed citations
17.
Myers, Evan R., Gillian D Sanders, Dhurjati Ravi, et al.. (2011). Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program.17 indexed citations
18.
Sanders, Gillian D, Benjamin Powers, Matthew J. Crowley, et al.. (2010). Exact Search Strategies.1 indexed citations
19.
Powers, Benjamin, Matthew J. Crowley, Evan R. Myers, et al.. (2010). Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 18.2 indexed citations
20.
Sanders, Gillian D, Benjamin Powers, Matthew J. Crowley, et al.. (2010). Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.